• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is Persistent Thick Copious Mucus a Long-Term Symptom of COVID-19?持续性浓稠大量黏液是新冠病毒感染的长期症状吗?
Eur J Case Rep Intern Med. 2020 Dec 29;7(12):002145. doi: 10.12890/2020_002145. eCollection 2020.
2
Histamine-induced changes in rat tracheal goblet cell mucin store and mucosal edema.组胺诱导大鼠气管杯状细胞粘蛋白储存和黏膜水肿的改变。
Histochem Cell Biol. 2013 May;139(5):717-26. doi: 10.1007/s00418-012-1060-y. Epub 2012 Dec 7.
3
New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.哮喘和 COPD 气道黏液高分泌的新药物治疗:靶向细胞内信号通路。
J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802.
4
Follow-up of adults with noncritical COVID-19 two months after symptom onset.非重症 COVID-19 成人患者症状发作后两个月的随访。
Clin Microbiol Infect. 2021 Feb;27(2):258-263. doi: 10.1016/j.cmi.2020.09.052. Epub 2020 Oct 5.
5
Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.辛伐他汀减轻脂多糖诱导的大鼠气道黏液高分泌。
Chin Med J (Engl). 2008 Sep 5;121(17):1680-7.
6
Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.哮喘中的黏液过度分泌:作为药物治疗靶点的细胞内信号通路。
Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76. doi: 10.1097/ACI.0b013e328334643a.
7
Neutrophil elastase inhibitor, ONO-5046 suppresses ozone-induced airway mucus hypersecretion in guinea pigs.
Eur J Pharmacol. 2000 Feb 25;390(1-2):197-202. doi: 10.1016/s0014-2999(99)00921-8.
8
Mucin-producing elements and inflammatory cells.产生黏蛋白的成分和炎症细胞。
Novartis Found Symp. 2002;248:51-68; discussion 68-75, 277-82.
9
Spontaneous remission of edema and regranulation of goblet cells in rat tracheae after capsaicin-induced acute inflammation.辣椒素诱导大鼠气管急性炎症后水肿的自发消退及杯状细胞的再形成
Anat Embryol (Berl). 2003 Mar;206(4):301-9. doi: 10.1007/s00429-002-0299-9. Epub 2003 Jan 21.
10
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.在 SARS-CoV-2 感染中发病时存在头痛与新冠后长期头痛和疲劳相关:一项病例对照研究。
Cephalalgia. 2021 Nov;41(13):1332-1341. doi: 10.1177/03331024211020404. Epub 2021 Jun 16.

引用本文的文献

1
Impact of Nebulized BromAc on Mucus Plug Clearance in a Mechanically Ventilated Ex Vivo Ovine Lung Model of Obstructive Respiratory Conditions.雾化溴己新对阻塞性呼吸疾病机械通气离体绵羊肺模型中黏液栓清除的影响
Life (Basel). 2024 Sep 3;14(9):1111. doi: 10.3390/life14091111.
2
Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration.慢性气道上皮缺氧通过黏液高浓度使黏液阻塞性肺病的损伤加重。
Sci Transl Med. 2023 Jun 7;15(699):eabo7728. doi: 10.1126/scitranslmed.abo7728.
3
Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy.羧甲司坦的黏液溶解和抗氧化特性作为COVID-19治疗策略
Life (Basel). 2022 Nov 8;12(11):1824. doi: 10.3390/life12111824.
4
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease.新型冠状病毒病肺病中黏液积聚的流行情况和机制。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1336-1352. doi: 10.1164/rccm.202111-2606OC.
5
Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies.HMGB1 基因改变、RNA 表达谱和 DNA 甲基化与恶性肿瘤。
J Cell Mol Med. 2022 Aug;26(15):4322-4332. doi: 10.1111/jcmm.17454. Epub 2022 Jun 28.
6
Influence of SARS-CoV-2 on airway mucus production: A review and proposed model.SARS-CoV-2 对气道黏液产生的影响:综述与模型构建
Vet Pathol. 2022 Jul;59(4):578-585. doi: 10.1177/03009858211058837. Epub 2021 Nov 18.
7
Mucus targeting as a plausible approach to improve lung function in COVID-19 patients.针对黏液作为改善 COVID-19 患者肺功能的一种可行方法。
Med Hypotheses. 2021 Nov;156:110680. doi: 10.1016/j.mehy.2021.110680. Epub 2021 Sep 15.
8
Evolving phenotypes of non-hospitalized patients that indicate long COVID.提示长新冠的非住院患者不断变化的表型。
BMC Med. 2021 Sep 27;19(1):249. doi: 10.1186/s12916-021-02115-0.
9
Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data.新冠后综合征:疾病病毒感染后阶段的持续症状。当前数据的系统综述
Front Med (Lausanne). 2021 May 4;8:653516. doi: 10.3389/fmed.2021.653516. eCollection 2021.
10
Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information.定义“长新冠”的挑战:文献、电子健康记录和患者报告信息之间存在显著差异。
medRxiv. 2021 Mar 26:2021.03.20.21253896. doi: 10.1101/2021.03.20.21253896.

本文引用的文献

1
Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.COVID-19肺炎中的气道卫生:3名重症游轮员工的治疗反应
Am J Case Rep. 2020 Aug 18;21:e926596. doi: 10.12659/AJCR.926596.
2
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
3
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
4
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.对新冠病毒疾病(COVID-19)患者的尸检显示,肺部出现弥漫性肺泡损伤,伴有严重的毛细血管充血,肺部及其他器官呈现出多样化的表现,提示存在血管功能障碍。
Histopathology. 2020 Aug;77(2):198-209. doi: 10.1111/his.14134. Epub 2020 Jul 5.
5
Coronavirus: Update Related to the Current Outbreak of COVID-19.冠状病毒:与当前COVID-19疫情相关的最新情况
Infect Dis Ther. 2020 Jun;9(2):241-253. doi: 10.1007/s40121-020-00295-5. Epub 2020 Apr 8.
6
Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.确诊 2019 年新型冠状病毒病患者的眼部表现。
Br J Ophthalmol. 2020 Jun;104(6):748-751. doi: 10.1136/bjophthalmol-2020-316304. Epub 2020 Apr 7.
7
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病(COVID-19)轻至中度形式的临床特征:一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
8
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.95 例 SARS-CoV-2 感染患者的胃肠道症状。
Gut. 2020 Jun;69(6):997-1001. doi: 10.1136/gutjnl-2020-321013. Epub 2020 Apr 2.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

持续性浓稠大量黏液是新冠病毒感染的长期症状吗?

Is Persistent Thick Copious Mucus a Long-Term Symptom of COVID-19?

作者信息

Manckoundia Patrick, Franon Evelyne

机构信息

Department of Geriatrics and Internal Medicine, Dijon University Hospital, Dijon, France.

UMR Inserm/U1093 Cognition, Action, Sensorimotor Plasticity, University of Burgundy and Franche Comté, Dijon, France.

出版信息

Eur J Case Rep Intern Med. 2020 Dec 29;7(12):002145. doi: 10.12890/2020_002145. eCollection 2020.

DOI:10.12890/2020_002145
PMID:33457378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806295/
Abstract

INTRODUCTION

The typical clinical picture of COVID-19 is gradually becoming clearer, both in the acute phase and in the long-term. However, new symptoms are gradually being identified. We describe a long-term symptom that has not yet been reported.

CASE DESCRIPTION

A 49-year-old man consulted for persistent asthenia. The general practitioner found a fever (39.2°C), and COVID-19 was confirmed by the polymerase chain reaction test. Further symptoms appeared, notably thick, white, painless tracheal hypersecretion for 3 months before diminishing, without disappearing.

CONCLUSION

Non-inflammatory tracheal hypersecretion, not yet reported in COVID-19, may be an additional long-term symptom. The hyperstimulation of tracheal goblet cells secreting mucus is 1 pathophysiological hypothesis.

LEARNING POINTS

Painless, non-inflammatory tracheal hypersecretion, which has yet to be described in post-acute COVID-19, may be an additional long-term symptom of the disease.The hyperstimulation of mucus-secreting tracheal goblet cells by the coronavirus, leading to tracheal discomfort and a feeling of suffocation, is 1 pathophysiological hypothesis.

摘要

引言

COVID-19的典型临床症状在急性期和长期病程中都逐渐变得更加清晰。然而,新的症状也在逐渐被发现。我们描述一种尚未被报道过的长期症状。

病例描述

一名49岁男性因持续乏力前来就诊。全科医生发现其发热(39.2°C),经聚合酶链反应检测确诊为COVID-19。随后出现了其他症状,尤其是持续3个月的浓稠、白色、无痛性气管分泌物增多,之后有所减轻但未消失。

结论

非炎性气管分泌物增多这一在COVID-19中尚未被报道的症状,可能是一种额外的长期症状。分泌黏液的气管杯状细胞过度刺激是一种病理生理假设。

学习要点

无痛性、非炎性气管分泌物增多这一在急性COVID-19后尚未被描述的症状,可能是该疾病的另一种长期症状。冠状病毒对分泌黏液的气管杯状细胞的过度刺激,导致气管不适和窒息感,是一种病理生理假设。